44 related articles for article (PubMed ID: 22253285)
21. Aberrant MFN2 transcription facilitates homocysteine-induced VSMCs proliferation via the increased binding of c-Myc to DNMT1 in atherosclerosis.
Xu L; Hao H; Hao Y; Wei G; Li G; Ma P; Xu L; Ding N; Ma S; Chen AF; Jiang Y
J Cell Mol Med; 2019 Jul; 23(7):4611-4626. PubMed ID: 31104361
[TBL] [Abstract][Full Text] [Related]
22. TGF-β1 downregulates AT1 receptor expression via PKC-δ-mediated Sp1 dissociation from KLF4 and Smad-mediated PPAR-γ association with KLF4.
Zhang XH; Zheng B; Gu C; Fu JR; Wen JK
Arterioscler Thromb Vasc Biol; 2012 Apr; 32(4):1015-23. PubMed ID: 22282354
[TBL] [Abstract][Full Text] [Related]
23. TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner.
Chan J; Prado-Lourenco L; Khachigian LM; Bennett MR; Di Bartolo BA; Kavurma MM
Circ Res; 2010 Apr; 106(6):1061-71. PubMed ID: 20150555
[TBL] [Abstract][Full Text] [Related]
24. Characterization of the human intestinal CD98 promoter and its regulation by interferon-gamma.
Yan Y; Dalmasso G; Sitaraman S; Merlin D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G535-45. PubMed ID: 17023546
[TBL] [Abstract][Full Text] [Related]
25. Ras/ERK signaling pathway mediates activation of the p21WAF1 gene promoter in vascular smooth muscle cells by platelet-derived growth factor.
Lee B; Moon SK
Arch Biochem Biophys; 2005 Nov; 443(1-2):113-9. PubMed ID: 16248979
[TBL] [Abstract][Full Text] [Related]
26. [Mitochondrial fusion protein Mfn2 and cardiovascular diseases].
Yu HY; Guo YH; Gao W
Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):11-6. PubMed ID: 21417008
[TBL] [Abstract][Full Text] [Related]
27. Role of Sp1 in atherosclerosis.
Jiang JF; Zhou ZY; Liu YZ; Wu L; Nie BB; Huang L; Zhang C
Mol Biol Rep; 2022 Oct; 49(10):9893-9902. PubMed ID: 35715606
[TBL] [Abstract][Full Text] [Related]
28. MicroRNAs regulate vascular smooth muscle cell functions in atherosclerosis (review).
Yu X; Li Z
Int J Mol Med; 2014 Oct; 34(4):923-33. PubMed ID: 25197940
[TBL] [Abstract][Full Text] [Related]
29. Transcription factors: key regulatory targets of vascular smooth muscle cell in atherosclerosis.
Jiang Y; Qian HY
Mol Med; 2023 Jan; 29(1):2. PubMed ID: 36604627
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA regulation of vascular smooth muscle function and phenotype: early career committee contribution.
Maegdefessel L; Rayner KJ; Leeper NJ
Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):2-6. PubMed ID: 25520518
[No Abstract] [Full Text] [Related]
31. Aberrant DNA methylation in the pathogenesis of atherosclerosis.
Hai Z; Zuo W
Clin Chim Acta; 2016 May; 456():69-74. PubMed ID: 26944567
[TBL] [Abstract][Full Text] [Related]
32. The promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells.
Sorianello E; Soriano FX; Fernández-Pascual S; Sancho A; Naon D; Vila-Caballer M; González-Navarro H; Portugal J; Andrés V; Palacín M; Zorzano A
Cardiovasc Res; 2012 Apr; 94(1):38-47. PubMed ID: 22253285
[TBL] [Abstract][Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
